Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inhee Choi

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry|March 21, 2022
Drug-like molecules with anti-trypanothione synthetase activity identified by high throughput screeningDiego Benítez, Jaime Franco, Florencia Sardi, et al.
Bioorganic Chemistry|September 24, 2024
Design, synthesis, biological evaluation study of spirocyclic POM analogues as novel MmpL3 anti-tubercular agentYoung Mi Kim, Yumi Park, Eun Soon Son, et al.
European Journal of Medicinal Chemistry|November 2, 2013
Synthesis and evaluation of hexahydropyrimidines and diamines as novel hepatitis C virus inhibitorsJong Yeon Hwang, Hee-Young Kim, Suyeon Jo, et al.
Structure (London, England : 1993)|September 14, 2017
Structure of Ddn, the Deazaflavin-Dependent Nitroreductase from Mycobacterium tuberculosis Involved in Bioreductive Activation of PA-824Susan E Cellitti, Jennifer Shaffer, David H Jones, et al.
Structure (London, England : 1993)|January 17, 2012
Structure of Ddn, the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis involved in bioreductive activation of PA-824Susan E Cellitti, Jennifer Shaffer, David H Jones, et al.
Journal of Medicinal Chemistry|July 16, 2011
Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824)Joseph Cherian, Inhee Choi, Amit Nayyar, et al.
Bioorganic & Medicinal Chemistry|October 19, 2020
Discovery of thienothiazolocarboxamide analogues as novel anti-tubercular agentGuanghai Jin, Young Mi Kim, Aram Lee, et al.
Cell Chemical Biology|July 28, 2022
Pharmacological perturbation of thiamine metabolism sensitizes Pseudomonas aeruginosa to multiple antibacterial agentsHyung Jun Kim, Yingying Li, Michael Zimmermann, et al.
Journal of Medicinal Chemistry|May 30, 2014
Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agentSunhee Kang, Ryang Yeo Kim, Min Jung Seo, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
Serendipitous discovery of 2-((phenylsulfonyl)methyl)-thieno[3,2-d]pyrimidine derivatives as novel HIV-1 replication inhibitorsJunwon Kim, Jeongjin Kwon, Doohyun Lee, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Journal of Enzyme Inhibition and Medicinal Chemistry|March 21, 2022
Drug-like molecules with anti-trypanothione synthetase activity identified by high throughput screeningDiego Benítez, Jaime Franco, Florencia Sardi, et al.
Bioorganic Chemistry|September 24, 2024
Design, synthesis, biological evaluation study of spirocyclic POM analogues as novel MmpL3 anti-tubercular agentYoung Mi Kim, Yumi Park, Eun Soon Son, et al.
European Journal of Medicinal Chemistry|November 2, 2013
Synthesis and evaluation of hexahydropyrimidines and diamines as novel hepatitis C virus inhibitorsJong Yeon Hwang, Hee-Young Kim, Suyeon Jo, et al.
Structure (London, England : 1993)|September 14, 2017
Structure of Ddn, the Deazaflavin-Dependent Nitroreductase from Mycobacterium tuberculosis Involved in Bioreductive Activation of PA-824Susan E Cellitti, Jennifer Shaffer, David H Jones, et al.
Structure (London, England : 1993)|January 17, 2012
Structure of Ddn, the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis involved in bioreductive activation of PA-824Susan E Cellitti, Jennifer Shaffer, David H Jones, et al.
Journal of Medicinal Chemistry|July 16, 2011
Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824)Joseph Cherian, Inhee Choi, Amit Nayyar, et al.
Bioorganic & Medicinal Chemistry|October 19, 2020
Discovery of thienothiazolocarboxamide analogues as novel anti-tubercular agentGuanghai Jin, Young Mi Kim, Aram Lee, et al.
Cell Chemical Biology|July 28, 2022
Pharmacological perturbation of thiamine metabolism sensitizes Pseudomonas aeruginosa to multiple antibacterial agentsHyung Jun Kim, Yingying Li, Michael Zimmermann, et al.
Journal of Medicinal Chemistry|May 30, 2014
Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agentSunhee Kang, Ryang Yeo Kim, Min Jung Seo, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
Serendipitous discovery of 2-((phenylsulfonyl)methyl)-thieno[3,2-d]pyrimidine derivatives as novel HIV-1 replication inhibitorsJunwon Kim, Jeongjin Kwon, Doohyun Lee, et al.
Pageof 13